Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Mogamulizumab can cause hair loss and skin rashes.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Baricitinib may effectively treat nail changes in alopecia areata.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Ebastine may help regrow hair in alopecia areata patients.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Rituximab can cause skin issues, but baricitinib may help improve them.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.